Browsing Category
Drug research
ReNeuron Group Focuses on Exosome Technology Validation and Seeks New Investors
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), a stem cell-derived exosome-based drug delivery platform developer, is currently seeking new investors to enable the company to trade as a going concern following its exit from administration. The…
Study finds that weight-loss injections can be associated with a condition that causes blindness
A study found that people who were prescribed a weight loss injection are at an increased risk of developing a condition in the eye which can cause blindness.
Researchers found that diabetics who took semaglutide (also known by the…
Weight-loss drugs to boom with generic versions
Experts have predicted that weight-loss medicines will see a boom in popularity, now that the first generic versions are available at lower prices than the original drugs.
Media-dubbed "skinny jabs", these injections can help people to…
Supplements ‘Ozempic Face’ to counter side effects of rapid weight-loss
Nestle will sell dietary supplements that counter the effects of weight loss drugs to "Ozempic Face".
The company announced that it would launch products to "complement" weight loss treatments. These include hair growth supplements and…
Eli Lilly’s Alzheimer’s drug receives support from US advisory panel
Eli Lilly's Alzheimer's treatment donanemab is getting closer to US approval after an independent panel of scientific experts determined that the benefits outweighed the risk.
The US Food and Drug Administration convened a committee of…
Research shows that weight-loss medications can reduce cancer risk by up to a fifth.
Doctors said that weight-loss drugs are a powerful weapon in the fight against cancer. They have "enormous" potential to shrink tumours and prevent new cases.
Blockbuster injections such as Wegovy have revolutionised the treatment of…
Doctors are excited by the melanoma vaccine trial results.
According to doctors, the world's first personalised cancer vaccine for melanoma reduces the risk that patients will die or have the disease return.
According to the 2020 statistics from World Research Fund International, melanoma…
AstraZeneca wants to double its revenues to $80 billion by 2030
AstraZeneca is the largest drug manufacturer in Britain. It has set a bold goal to achieve $80bn ($63bn) by 2030 through treatments for cancer and rare diseases.
Pascal Soriot, the chief executive of the company, presented the growth…
Novo Nordisk will test the effects of weight-loss drugs on alcohol consumption and liver disease.
Novo Nordisk wants to increase the use of its blockbuster treatments. It is testing their weight loss drugs to see if they reduce alcohol consumption and treat alcoholic hepatitis.
The Danish pharmaceutical company started recruiting for…
Sir John Bell, tsar of life sciences, believes that London is not the best place to raise funds.
Sir John Bell, one of Britain's leading life sciences leaders, warned of an imminent exodus of pharmaceutical companies from London, calling the City "a bad place to raise funds".
Sir John, a veteran of the industry known for his crucial…
Rare genetic disease treatment becomes the world’s most costly drug at $4.25mn
In the US, a new gene therapy that treats a rare genetic disorder that attacks the nervous system central of young children is priced at $4.25mn. This makes it the most costly drug in history.
Lenmeldy, a medicine developed by Orchard…
Novo-Nordisk gives me a boost with a double dose of power.
Most people prefer to take a pill rather than inject themselves with medication when they are sick. This simple fact helped Novo-Nordisk, (stock ticker:NOVO), to become the third-most valuable holding in my “forever fund” after renewed hope…
AstraZeneca purchases rare diseases group in order to boost drug pipeline
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its efforts to boost the pipeline of drugs.
AstraZeneca agreed to…
AstraZeneca builds £450m vaccine center in Liverpool as boost for UK
AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of AstraZeneca said that Rishi Sunak’s policies discouraged…
Shares of Viking Therapeutics more than doubled on’statistically important’ weight loss…
The shares of US biotech Viking Therapeutics have more than doubled since trial results for its weight-loss drug beat existing treatments from Novo Nordisk & Eli Lilly.
In a mid-stage 13-week trial, Viking reported that its…
AstraZeneca unveils successes in treatment of lung cancer
AstraZeneca announced on Monday that its top drug has shown promising results in treating early-stage lung cancer by slowing down the progression of the disease.
The company announced that its Tagrisso drug, which is a best-seller,…
Eli Lilly to launch weight loss drug in UK ‘within a few weeks’
Mounjaro, a weight-loss drug that is available in an injectable pen in Great Britain in the near future for the treatment of diabetes and obesity will be made available by Eli Lilly after the UK medicines regulator approved its sale on…
Data shows that expired Pfizer Covid antiviral medications will cost Europe $2.2bn.
According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who could receive the medication led to millions…